Navi Mumbai, India

Aditi Poddar

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Evonik Operations Gmbh. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aditi Poddar: Innovator in Pharmaceutical Technology

Introduction

Aditi Poddar is a prominent inventor based in Navi Mumbai, India. She has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. Her work focuses on enhancing the efficacy and safety of medications through advanced formulations.

Latest Patents

Aditi holds a patent for a novel Pellet and Multi-Unit Pellet System (MUPS). This invention involves a pellet that contains a core with one or more biologically active ingredients, surrounded by a specialized coating layer. The coating consists of a mixture of two polymers, designed to optimize the release and absorption of the active ingredients. This innovative approach aims to improve patient outcomes by providing a more effective drug delivery mechanism.

Career Highlights

Aditi is currently employed at Evonik Operations GmbH, where she continues to push the boundaries of pharmaceutical innovation. Her expertise in polymer chemistry and drug formulation has positioned her as a key player in her field. With a focus on research and development, she is dedicated to creating solutions that address the challenges faced in medication delivery.

Collaborations

Aditi collaborates with talented professionals in her field, including Suresh Doke and Ashish Guha. These partnerships enhance her research efforts and contribute to the advancement of pharmaceutical technologies.

Conclusion

Aditi Poddar's contributions to the pharmaceutical industry through her innovative patent and collaborative efforts highlight her role as a leading inventor. Her work continues to pave the way for advancements in drug delivery systems, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…